Beta Amyloid Peptide: Beta Amyloid Peptide: Research Paper : [Establishment of a new cell model mimicking Alzheimer's disease by knocking down SORL1 expression]

Beta Amyloid Peptide: Research Paper : [Establishment of a new cell model mimicking Alzheimer's disease by knocking down SORL1 expression]

[Establishment of a new cell model mimicking Alzheimer's disease by knocking down SORL1 expression]

Abstract

Objective: To establish a cell model mimicking Alzheimer's disease (AD) by knocking down SORL1 gene and compare the viability, apoptosis, and expressions of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in this model with a traditional Alzheimer's disease cell model.

Methods: A traditional cell model of AD was established by inducing N2a cells with Aβ25-35, and the optimal Aβ25-35 concentration was determined by assessing the cell viability changes. Another cell model of AD was established by transfecting N2a cells with SORL1-shRNA lentiviral vector, and SORL1 expression in the transfected cells were detected using Western blotting and qRT-PCR. With wild-type N2a cells without any treatment and cells transfected with a scramble shRNA as the control groups, the two cell models were examined for cell viability with MTT assay, cell apoptosis with flow cytometry, and TNF-α and IL -1β levels in the culture supernatant with ELISA.

Results: The two cell models of AD showed obviously decreased viability and increased cell apoptosis compared with the untreated control cells or cells transfected with a scramble shRNA (P < 0.05); no significant difference was found in the cell viability and apoptosis rate between the two AD cell models or between the two control groups (P>0.05). Significantly increased expressions of TNF-α and IL-1β were observed in both of the two cell models compared with their respective control groups (P < 0.05) without significant differences between the two cell models or between the two control groups (P>0.05).

Conclusions: A new AD cell model similar to Aβ25-35-induced AD model can be established by SORL1 knockdown in N2a cells.

Keywords: Alzheimer's disease; N2a cell; SORL1; transfection.

This article originally appeared in the "https://pubmed.ncbi.nlm.nih.gov/33177021/" and has their copyrights. We do not claim copyright on the content. This information is for research purposes only. This Blog is made available by publishers for educational purposes only as well as to give you general information and a general understanding , not to provide specific advice. By using this blog site you understand that there is no client relationship between you and the Blog publisher. The Blog should not be used as a substitute for competent research advice.  



No comments:

Post a Comment

The secret of Eta Black by Ananya Sharma

The secret of Eta Black by Ananya Sharma  A man sitting behind the bars named Eta black has no clue what is happening with him. He was searc...

Blog Archive

Pageviews

Beta Amyloid Research